Gene therapy for age-related macular degeneration
Age-related macular degeneration is the most common cause of untreatable blindness in the world, and its prevalence is increasing. Current therapies for neovascular age-related macular degeneration aim to prevent growth of the abnormal retinal blood vessels that could leak and cause rapid visual los...
Main Author: | MacLaren, RE |
---|---|
Format: | Journal article |
Published: |
Elsevier
2015
|
Similar Items
-
CRISPR Manipulation of Age-Related Macular Degeneration Haplotypes in the Complement System: Potential Future Therapeutic Applications/Avenues
by: Ahmed Salman, et al.
Published: (2024-01-01) -
The Role of Inflammation in Age-Related Macular Degeneration—Therapeutic Landscapes in Geographic Atrophy
by: Grace A. Borchert, et al.
Published: (2023-08-01) -
CDHR1-related late-onset macular dystrophy: further insights
by: Yusuf, IH, et al.
Published: (2020) -
Recent Advances in Age-Related Macular Degeneration Therapies
by: Marie Fabre, et al.
Published: (2022-08-01) -
Chimpanzee adenovirus-mediated multiple gene therapy for age-related macular degeneration
by: Selena Wei-Zhang, et al.
Published: (2023-10-01)